Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice

被引:30
作者
Erlandsson, MC [1 ]
Islander, U
Moverare, S
Ohlsson, C
Carlsten, H
机构
[1] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden
[2] Univ Gothenburg, Ctr Bone Res, Sahlgrenska Acad, Dept Internal Med, Gothenburg, Sweden
关键词
genistein; estradiol; lymphopoiesis; bone mineral density; uterus;
D O I
10.1111/j.1600-0463.2005.apm_113502.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The isoflavone genistein (Gen) is a naturally occurring phytoestrogen found in high concentrations in soy. The biological effects of Gen have been extensively studied. The immunomodulating properties of Gen are, however, less well investigated and the results are contradictory. Our aim was to study possible estrogen agonistic and antagonistic properties of Gen in uterus, bone, lymphopoiesis and B-cell function by comparing effects in castrated and intact female mice, respectively Oophorectomized (OVX) and sham-operated mice were treated with s.c. doses of 17 beta-estradiol (E2) (0.16 mg/kg), Gen (50 mg/kg), or vehicle (olive oil) as control. Effects on bone mineral density (BMD) were studied using peripheral quantitative computerized tomography, uterine and thymus weights were examined, lymphopoiesis in thymus and bone marrow was analyzed using flow cytometry, and the frequency of immunoglobulin-producing B cells in bone marrow and spleen was studied using an ELISPOT assay. Gen was clearly antagonizing endogenous estrogen in sham-operated female mice as shown by inhibiting the uterine weight and by increasing the frequency of B lymphopoietic cells in bone marrow. The only agonistic effect of Gen was shown by increased BMD in OVX mice. Our results are discussed in the context of estrogen receptor biology.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 38 条
[1]  
CARLSTEN H, 1990, CLIN EXP IMMUNOL, V80, P467
[2]   Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice [J].
Carlsten, H ;
Verdrengh, M ;
Taube, M .
INFLAMMATION RESEARCH, 1996, 45 (01) :26-30
[3]   AN IMMUNOENZYME PROCEDURE FOR ENUMERATING FIBRONECTIN-SECRETING CELLS [J].
CZERKINSKY, CC ;
NILSSON, LA ;
TARKOWSKI, A ;
OUCHTERLONY, O ;
JEANSSON, S ;
GRETZER, C .
JOURNAL OF IMMUNOASSAY, 1984, 5 (3-4) :291-302
[4]  
D'Elia HF, 2003, J RHEUMATOL, V30, P1456
[5]  
DAHLGREN UI, 1991, IMMUNOLOGY, V74, P74
[6]   Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice [J].
Erlandsson, MC ;
Jonsson, CA ;
Islander, U ;
Ohlsson, C ;
Carlsten, H .
IMMUNOLOGY, 2003, 108 (03) :346-351
[7]   Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice [J].
Erlandsson, MC ;
Jonsson, CA ;
Lindberg, MK ;
Ohlsson, C ;
Carlsten, H .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (02) :319-327
[8]   Role of oestrogen receptors α and β in immune organ development and in oestrogen-mediated effects on thymus [J].
Erlandsson, MC ;
Ohlsson, C ;
Gustafsson, JÅ ;
Carlsten, H .
IMMUNOLOGY, 2001, 103 (01) :17-25
[9]   INTERACTION IN IMMATURE MOUSE OF POTENT OESTROGENS WITH COUMESTROL GENISTEIN AND OTHER UTERO-VAGINOTROPHIC COMPOUNDS OF LOW POTENCY [J].
FOLMAN, Y ;
POPE, GS .
JOURNAL OF ENDOCRINOLOGY, 1966, 34 (02) :215-&
[10]  
HANNA N, 1983, J IMMUNOL, V130, P974